THERAPYX, INC.

Biotech · Private

FAPXIL, an oral sustained-release micro-particulate formulation of Interleukin-10 for Familial Adenomatous Polyposis

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Total capital: $17.9M

Federal grants: $17.9M; 23 awards · 2014–2025; Rank in peer group#12 of 514
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 5 pending · first 2020; Rank in peer group#142 of 514

Capital timeline

Latest events

Apr 2025Federal grantHealth and Human S · Phase II · IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$960K
Mar 2024Federal grantHealth and Human S · Phase II · IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$960K
May 2023Federal grantHealth and Human S · Phase II · IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$1.2M
Jun 2022Federal grantHealth and Human S · Phase II · Experimental Gonococcal Vaccine$1M
Apr 2022Federal grantHealth and Human S · Phase II · Therapy and Prophylaxis for Genital Tract Infection$915K
Feb 2022Federal grantHealth and Human S · Phase I · OMV vaccine against Gonorrhea$300K
Jun 2021Federal grantHealth and Human S · Phase II · Experimental Gonococcal Vaccine$1M

Show 16 earlier federal awards

Apr 2021Federal grantHealth and Human S · Phase II · Therapy and Prophylaxis for Genital Tract Infection$1M
Mar 2021Federal grantHealth and Human S · Phase II · IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$848K
Jul 2020Federal grantHealth and Human S · Phase II · Experimental Gonococcal Vaccine$807K
May 2020Federal grantHealth and Human S · Phase II · Therapy and Prophylaxis for Genital Tract Infection$1M
Feb 2020Federal grantHealth and Human S · Phase II · IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$858K
Jul 2019Federal grantHealth and Human S · Phase I · Encapsulated anti-IL-10 for the immune therapy of gonorrhea infection$239K
May 2019Federal grantHealth and Human S · Phase II · Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$1.0M
Mar 2019Federal grantHealth and Human S · Phase II · IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$389K
Jul 2018Federal grantHealth and Human S · Phase I · PLGA encapsulated polyphenols to ameliorate IBD.$320K
Apr 2018Federal grantHealth and Human S · Phase II · Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$1.0M
Jan 2018Federal grantHealth and Human S · Phase II · Experimental Gonococcal Vaccine$989K
Jun 2017Federal grantHealth and Human S · Phase II · Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$1.0M
Feb 2017Federal grantHealth and Human S · Phase II · Experimental Gonococcal Vaccine$805K
Sep 2016Federal grantHealth and Human S · Phase I · Oral sustained-release IL-10 microspheres for therapy of IBD$296K
Apr 2015Federal grantHealth and Human S · Phase II · Therapy and Prophylaxis for Genital Tract Infection$749K
Dec 2014Federal grantHealth and Human S · Phase I · Experimental Gonococcal Vaccine$271K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grants#12 · top 2%
Granted patents#142 · top 28%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 7

Nov 22, 2022GrantedCompositions For Stabilizing And Delivering ProteinsUSPTOUS 11,504,329
Jul 28, 2020GrantedCompositions For Stabilizing And Delivering ProteinsUSPTOUS 10,722,468
Feb 9, 2017PendingCompositions And Methods For Treating Inflammation-associated Disorders Of The Gastrointestinal TractUSPTOApplication 15230866

Show all 7 patent records

Compositions For Stabilizing And Delivering ProteinsNov 22, 2022 · US 11,504,329Granted
Compositions For Stabilizing And Delivering ProteinsJul 28, 2020 · US 10,722,468Granted
Compositions And Methods For Treating Inflammation-associated Disorders Of The Gastrointestinal TractFeb 9, 2017 · Application 15230866Pending
Immune Modulators in Combination with Radiation Treatment For Advanced Pancreatic CancerApplication 62747830Pending
Compositions For Stabilizing And Delivering ProteinsApplication PCTUS2015045402Pending
Compositions And Methods For Treating Inflammation-associated Disorders Of The Gastrointestinal TractApplication 62201733Pending
Compositions For Stabilizing And Delivering ProteinsApplication 62037492Pending

PLEIOGENIX INC.Similar federal contract value in Biotech · null in contracts
NeoStem, Inc.Similar federal contract value in Biotech · null in contracts
SYMPHONY BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
Cure Network Dolby Acceleration Partners LLCSimilar federal contract value in Biotech · null in contracts
Altor BioScience, LLCSimilar federal contract value in Biotech · null in contracts
ASCLEPIA TECHNOLOGY LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.